Degnan Chris 4
4 · Galera Therapeutics, Inc. · Filed Nov 8, 2019
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Stock Option
2019-11-06+229,513→ 229,513 totalExercise: $12.00Exp: 2029-11-05→ Common Stock (229,513 underlying)
Footnotes (1)
- [F1]The options vests and becomes exercisable with respect to 25% on October 21, 2020 with the remaining shares vesting and becoming exercisable in equal monthly installments over a three year period thereafter.